Abcl stock forecast 2025 trader discussions on ABCL stock

Trader discussions on ABCL stock forecast 2025 often point to the stock’s beta value above 1.5, reflecting aggressive swings relative to the S&P The general public-- including retail investors -- own 32% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. We recently compiled a list of the 10 Best Multibagger Penny Stocks of 2025 . In this article, we are going to take a look at where AbCellera Biologics Inc. (NASDAQ:ABCL) stands against the other multibagger penny stocks. Data-driven ABCL stock forecast 2025 accounts for AbCellera’s strategic collaborations, estimating new deal pipelines could boost 2025 revenues by $50M+. This assumes steady onboarding of discovery projects from Q4 2024 onwards.